trial · primary record
XTX501
Metastatic NSCLC - Non-Small Cell Lung Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 180 |
| Primary completion | 2029-11 |
| Primary endpoint | Incidence of Dose Limiting Toxicities (DLTs) in Part 1A |
| Registry ID | NCT07688577 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:43:46.866Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07688577
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.